The reciprocating holder apparatus is ideal for automatic drug release testing for smaller, low dose delivery systems which may require different media and agitation rates to characterize the release of the API from the drug formulation or device. Although it was originally developed for testing small transdermal systems it has become much more flexible for testing other dosage forms such as osmotic pumps, drug eluting stents, bead formulations and pacemaker leads.
